Clinical trials
Inflammatory Bowel Diseases trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 7 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Janssen Research & Development, LLC | 4 |
| GlaxoSmithKline | 2 |
| Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | 2 |
| Pfizer | 2 |
| Spyre Therapeutics, Inc. | 2 |
| Takeda | 2 |
| AbbVie | 1 |
| Astellas Pharma Europe Ltd. | 1 |
| Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 35 |
| Crohn Disease | 18 |
| Colitis, Ulcerative | 17 |
| Colitis | 5 |
| Anemia | 2 |
| Gastrointestinal Diseases | 2 |
| Anemia, Iron-Deficiency | 1 |
| Clostridium Infections | 1 |
| Fistula | 1 |
| Gastroenteritis | 1 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.